464 related articles for article (PubMed ID: 31320454)
21. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
[TBL] [Abstract][Full Text] [Related]
22. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
Shi Z; Wu H; Luo J; Sun X
Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
[TBL] [Abstract][Full Text] [Related]
23. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
Calvier L; Boucher P; Herz J; Hansmann G
Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
[TBL] [Abstract][Full Text] [Related]
25. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
26. Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
Quatredeniers M; Nakhleh MK; Dumas SJ; Courboulin A; Vinhas MC; Antigny F; Phan C; Guignabert C; Bendifallah I; Vocelle M; Fadel E; Dorfmüller P; Humbert M; Cohen-Kaminsky S
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L445-L455. PubMed ID: 30543306
[TBL] [Abstract][Full Text] [Related]
27. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
Kong D; Liu J; Lu J; Zeng C; Chen H; Duan Z; Yu K; Zheng X; Zou P; Zhou L; Lv Y; Zeng Q; Lu L; Li J; He Y
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):e172-e195. PubMed ID: 38572649
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
[TBL] [Abstract][Full Text] [Related]
29. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
[TBL] [Abstract][Full Text] [Related]
30. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
31. Cathepsin S promotes the development of pulmonary arterial hypertension.
Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner.
Kang T; Liu L; Tan F; Zhang D; Yu L; Jiang H; Qian W; Hua J; Zheng Z
Exp Cell Res; 2023 Mar; 424(2):113505. PubMed ID: 36736607
[TBL] [Abstract][Full Text] [Related]
33. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
34. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
35. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
[TBL] [Abstract][Full Text] [Related]
36. Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.
Chen J; Rodriguez M; Miao J; Liao J; Jain PP; Zhao M; Zhao T; Babicheva A; Wang Z; Parmisano S; Powers R; Matti M; Paquin C; Soroureddin Z; Shyy JY; Thistlethwaite PA; Makino A; Wang J; Yuan JX
Am J Physiol Lung Cell Mol Physiol; 2022 May; 322(5):L737-L760. PubMed ID: 35318857
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
38. CCR5 as a treatment target in pulmonary arterial hypertension.
Amsellem V; Lipskaia L; Abid S; Poupel L; Houssaini A; Quarck R; Marcos E; Mouraret N; Parpaleix A; Bobe R; Gary-Bobo G; Saker M; Dubois-Randé JL; Gladwin MT; Norris KA; Delcroix M; Combadière C; Adnot S
Circulation; 2014 Sep; 130(11):880-891. PubMed ID: 24993099
[TBL] [Abstract][Full Text] [Related]
39. Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin.
Kinoshita D; Shishido T; Takahashi T; Yokoyama M; Sugai T; Watanabe K; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Kishida S; Kadomatsu K; Abe JI; Takeishi Y; Konta T; Kubota I; Watanabe M
Sci Rep; 2020 Jun; 10(1):10345. PubMed ID: 32587339
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
